|
시장보고서
상품코드
2129030
분자 종양 보드 솔루션 시장 : 구성요소별, 솔루션별, 암 유형별, 최종 용도별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Molecular Tumor Board Solutions Market, By Component, By Solution, By Cancer Type, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
분자 종양 보드(MTB) 솔루션 시장 규모는 2025년에 18억 160만 달러로 평가되었고, 2026-2033년 CAGR 14.2%로 성장할 전망입니다.
분자 종양 보드(MTB) 솔루션 시장에는 소프트웨어 플랫폼, 임상 의사결정 지원 시스템, 유전체 분석 도구, 데이터 관리 플랫폼 및 관련 암 유형가 포함되어 있으며, 이를 통해 다학제적 종양학 팀이 복잡한 암 사례를 평가하고 관리할 수 있게 됩니다. 이러한 솔루션은 유전체 염기서열 분석 데이터, 병리 소견, 병력, 바이오마커, 투약 정보 및 기타 환자별 데이터를 결합하여 철저한 사례 평가와 맞춤형 치료 계획을 제공합니다.
분자 종양 보드 솔루션 시장 : 시장 역학
정밀 종양학 및 유전체 검사의 도입 확대와 임상 의사 결정 지원에 대한 수요 증가가 시장 수요를 견인할 것으로 예측됩니다.
정밀 종양학 및 종합적인 유전체 프로파일링의 채택 확대는 분자 종양 위원회 솔루션 시장의 성장을 견인하는 주요 요인입니다. 유전자 변이, 복제 수 변이, 유전자 융합, 바이오마커 및 기타 분자 이상은 차세대 염기서열 분석(NGS) 및 기타 최첨단 분자진단 기술의 보급으로 생성되는 점점 더 복잡해지는 데이터 세트의 일부입니다. 이러한 결과를 해석하기 위해서는 종양내과 전문의, 병리학자, 분자생물학자, 유전학자, 생물정보학자 등 다분야 전문가들이 자주 필요합니다. MTB 솔루션은 분자 데이터와 임상 데이터를 통합 및 정리하고, 유전체 분석 결과를 임상 권고 사항, 과학 문헌, 표적 치료제 및 관련 임상시험과 연결함으로써 이 과정을 원활하게 합니다. 이를 통해 학제 간 팀이 보다 체계적인 근거 기반의 치료에 대한 논의를 진행할 수 있게 됩니다. 1만 2,176명의 환자를 대상으로 한 34건의 조사를 분석한 2025년 의료 평가에 따르면, 환자의 20.8%가 분자 종양 위원회(MTB)가 제안한 치료를 받고 있는 것으로 나타나, 암 치료에서 MTB 기반 접근법의 역할이 확대되고 있음을 보여줍니다.
사례 준비를 간소화하고, 행정 업무 부담을 줄이며, 임상적 해석을 향상시킬 수 있는 디지털 및 AI 기반 분자 종양 위원회 솔루션에 대한 수요는 종양학 데이터의 양, 다양성 및 복잡성이 증가함에 따라 더욱 가속화되고 있습니다. 기존 MTB 절차에서는 다학제적 협의를 진행하기 전에 환자 기록, 유전자 염기서열 분석 보고서, 병리 소견, 과학 문헌, 치료 권고 사항 및 관련 임상시험 데이터를 수집하고 검토하는 데 막대한 시간과 노력이 소요되는 경우가 빈번했습니다. 임상 데이터와 분자 데이터를 단일 플랫폼에 통합함으로써, 디지털 MTB 플랫폼은 관련 환자 데이터에 대한 신속한 접근과 보다 효과적인 사례 검토를 가능하게 하여 이러한 과제를 극복하는 데 기여합니다. AI 및 고급 분석 기능을 통합함으로써 데이터 집계, 문헌 및 증거 검색, 바이오마커 분석, 기타 작업을 더욱 자동화할 수 있습니다.
분자 종양 보드(MTB) 솔루션 시장 : 세분화 분석
세계 분자 종양 보드(MTB) 솔루션 시장은 구성 요소, 솔루션, 암 유형, 최종 사용자 및 지역을 기준으로 세분화됩니다.
솔루션에 따라 시장은 6가지 범주로 분류됩니다. 즉, 임상 의사결정 지원, 유전체 데이터 분석, 데이터 분석, 보고서 작성 및 시각화, 환자 사례 관리, 기유형니다. 솔루션별로는 임상 의사결정 지원 부문이 시장에서 상당한 매출 점유율을 차지할 것으로 예측됩니다. 임상 의사결정 지원 플랫폼은 환자 데이터 통합, 분자 검사 결과 정리 및 해석, 사례 준비 효율화, 다직종 간 토론 촉진, 치료 권고 사항 문서화, 그리고 지속적인 환자 추적 관찰 지원에 필요한 디지털 인프라를 제공합니다. 예를 들어, 로슈(Roche)사의 ‘navify Clinical Hub for Tumor Boards’는 회의 조정 및 환자 목록 관리 기능을 제공합니다.
분자 종양 보드 솔루션 시장 : 지역별 분석
북미의 견고한 정밀 종양학 생태계, 광범위한 유전체 검사 인프라, 전문 암 센터의 광범위한 네트워크, 그리고 디지털 임상 의사결정 지원 기술의 보급은 모두 분자 종양 보드 솔루션 시장에서 이 지역의 지배적인 지위에 기여하고 있습니다. 특히 미국에는 의료 기관, 기술 기업, 그리고 유전자 분석, 임상 정보학, 분자 종양 보드 서비스에 종사하는 수많은 종양학 전문 그룹이 존재합니다. 유럽 시장을 주도하는 요인은 발달된 의료 시스템, 최첨단 암 연구 역량, 대학 부속 의료 센터, 그리고 정밀 의학의 활용 확대입니다. 이 지역의 각국은 분자 종양 위원회 절차의 표준화, 일반 암 치료에 유전체 검사의 통합 강화, 그리고 임상, 진단, 연구 팀 간의 협력 강화에 더욱 중점을 두고 있습니다.
목차
제1장 분자 종양 보드 솔루션 시장 개요
제2장 주요 요약
제3장 분자 종양 보드 솔루션 주요 시장 동향
제4장 분자 종양 보드 솔루션 산업 분석
제5장 분자 종양 보드 솔루션 시장 : 높아지는 지정학적 긴장의 영향
제6장 분자 종양 보드 솔루션 시장 구도
제7장 분자 종양 보드 솔루션 시장 : 컴포넌트별
제8장 분자 종양 보드 솔루션 시장 : 솔루션별
제9장 분자 종양 보드 솔루션 시장 : 암 유형별
제10장 분자 종양 보드 솔루션 시장 : 최종 용도별
제11장 분자 종양 보드 솔루션 시장 : 지역별
제12장 주요 벤더 분석 : 분자 종양 보드 솔루션 산업
제13장 AnalystView 전방위 전망
AJY 26.09.17Molecular Tumor Board Solutions Market size was valued at USD 1,801.6 Million in 2025, expanding to a CAGR of 14.2% from 2026 to 2033.
The molecular tumor board (MTB) solutions market includes software platforms, clinical decision-support systems, genomic interpretation tools, data-management platforms, and related Cancer Type that enable multidisciplinary oncology teams to evaluate and manage complex cancer cases. These solutions offer thorough case assessment and individualized treatment planning by combining genomic sequencing data, pathology findings, clinical history, biomarkers, medication information, and other patient-specific data.
Molecular Tumor Board Solutions Market- Market Dynamics
Increasing adoption of precision oncology & genomic testing and need for clinical decision support are expected to propel market demand
The increasing adoption of precision oncology and comprehensive genomic profiling is a key factor driving the growth of the molecular tumor board solutions market. Gene mutations, copy-number variations, gene fusions, biomarkers, and other molecular abnormalities are among the increasingly complex datasets produced by the widespread use of next-generation sequencing (NGS) and other cutting-edge molecular diagnostic technologies. Multidisciplinary experts, including as oncologists, pathologists, molecular biologists, geneticists, bioinformaticians, and others, are frequently needed to interpret these results. By integrating and organizing molecular and clinical data and connecting genomic findings with clinical recommendations, scientific literature, targeted medicines, and pertinent clinical trials, MTB solutions facilitate this process. This makes it possible for interdisciplinary teams to have better organized, evidence-based therapy conversations. 20.8% of patients got treatments suggested by molecular tumour boards, according to a 2025 healthcare assessment of 34 research including 12,176 patients, indicating the expanding role of MTB-based techniques in cancer treatment.
Demand for digital and AI-enabled molecular tumour board solutions that can simplify case preparation, lessen administrative workload, and improve clinical interpretation is being driven by the growing volume, diversity, and complexity of oncology data. Prior to multidisciplinary conversations, traditional MTB procedures frequently need a substantial amount of time and effort to gather and examine patient records, genetic sequencing reports, pathology findings, scientific literature, therapeutic recommendations, and pertinent clinical trial data. By consolidating clinical and molecular data into a single setting, digital MTB platforms help to overcome these obstacles by facilitating quicker access to pertinent patient data and more effective case review. Data aggregation, literature and evidence retrieval, biomarker interpretation, and other tasks can be further automated by integrating AI and advanced analytics.
Molecular Tumor Board Solutions Market- Segmentation Analysis:
The Global Molecular Tumor Board Solutions Market is segmented on the basis of Component, Solution, Cancer Type, End-Use, and Region.
The market is divided into six categories based on Solution: clinical decision support, genomic data interpretation, data analytics, reporting & visualization, patient case management, and others. By solution, clinical decision support segment is anticipated to have a considerable revenue share in the market. Clinical decision-support platforms provide the digital infrastructure needed to consolidate patient data, organize and interpret molecular findings, streamline case preparation, facilitate multidisciplinary discussions, document treatment recommendations, and support ongoing patient follow-up. Roche's navify Clinical Hub for Tumor Boards, for example, provides meeting coordination, patient-list management.
Molecular Tumor Board Solutions Market- Geographical Insights
North America's robust precision oncology ecosystem, vast genomic testing infrastructure, extensive network of specialized cancer centres, and widespread adoption of digital clinical decision-support technologies all contribute to the region's dominant position in the molecular tumour board solutions market. Healthcare facilities, technological companies, and oncology-focused groups engaged in genetic interpretation, clinical informatics, and molecular tumour board services are particularly prevalent in the United States. Developed healthcare systems, cutting-edge cancer research skills, university medical centres, and the growing use of precision medicine are what propel the European market. The region's nations are focusing more on standardizing molecular tumour board procedures, enhancing the incorporation of genomic testing into regular cancer treatment, and bolstering cooperation between clinical, diagnostic, and research teams.
India Molecular Tumor Board Solutions Market- Key Insights
India's rising cancer incidence, developing precision-oncology capabilities, improving diagnostic infrastructure, and increased access to genomic testing all contribute to the country's potential as a market for molecular tumor board solutions. With businesses like MedGenome and other specialized providers supporting the adoption of genomic-based cancer assessment and individualized treatment options, the nation is also fortifying its ecosystem of molecular diagnostics and genomic testing. However, a number of obstacles, such as unequal access to sophisticated oncology and the expensive cost of complete genetic sequencing, limit market expansion. The use of MTB solutions is anticipated to grow throughout India's main cancer centers and specialist oncology networks as genomic testing becomes more widely available and digital healthcare infrastructure advances.
Molecular Tumor Board Solutions Market- Competitive Landscape:
The molecular tumor board solutions market is highly competitive and continuously evolving, with participation from healthcare technology companies, diagnostic & genomic-testing providers, oncology software developers, academic medical centers, pharmaceutical companies, and specialized clinical decision-support firms. Market participants are differentiating themselves through advanced genomic interpretation, clinical decision support, workflow automation, electronic health record (EHR) integration, AI-enabled analytics, and seamless data management. A key competitive trend is the shift from basic digital tools for tumor board coordination toward integrated precision-oncology platforms. Patient records, genomic profiles, pathology data, therapy recommendations, scientific literature, and clinical trial data are all being integrated into a single workflow by these platforms.
Recent Developments:
In June 2025, Roche Diagnostics Japan enhanced its navify Tumor Board software to accommodate gene-panel testing for hematological malignancies, broadening the platform's molecular tumor-board capabilities beyond solid-tumor applications.
In May 2025, Tempus announced that 10 abstracts had been selected for presentation at the 2025 ASCO Annual Meeting, showcasing the company's advancements in AI-driven precision oncology and molecularly informed cancer care.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET KEY PLAYERS
- Roche
- Tempus AI, Inc.
- Caris Life Sciences
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Syapse, Inc.
- GenomOncology, LLC
- Molecular Health GmbH
- SOPHiA GENETICS
- QIAGEN N.V.
- Guardant Health, Inc.
- Myriad Genetics, Inc.
- NantHealth, Inc.
- MedGenome
- CureMatch
- Variantyx, Inc.
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033
- Software
- Services
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY SOLUTION- MARKET ANALYSIS, 2020-2033
- Clinical Decision Support
- Genomic Data Interpretation
- Data Analytics
- Reporting & Visualization
- Patient Case Management
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Hematological Malignancies
- Prostate Cancer
- Melanoma
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033
- Hospitals
- Specialized Cancer Centers
- Research Institutes
- Diagnostic Laboratories
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Molecular Tumor Board Solutions Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Molecular Tumor Board Solutions Market Snippet by Component
- 2.1.2. Molecular Tumor Board Solutions Market Snippet by Solution
- 2.1.3. Molecular Tumor Board Solutions Market Snippet by Cancer Type
- 2.1.4. Molecular Tumor Board Solutions Market Snippet by End-Use
- 2.1.5. Molecular Tumor Board Solutions Market Snippet by Country
- 2.1.6. Molecular Tumor Board Solutions Market Snippet by Region
- 2.2. Competitive Insights
3. Molecular Tumor Board Solutions Key Market Trends
- 3.1. Molecular Tumor Board Solutions Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Molecular Tumor Board Solutions Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Molecular Tumor Board Solutions Market Opportunities
- 3.4. Molecular Tumor Board Solutions Market Future Trends
4. Molecular Tumor Board Solutions Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Molecular Tumor Board Solutions Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Molecular Tumor Board Solutions Market Landscape
- 6.1. Molecular Tumor Board Solutions Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Molecular Tumor Board Solutions Market - By Component
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
- 7.1.2. Software
- 7.1.3. Services
8. Molecular Tumor Board Solutions Market - By Solution
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Solution, 2025 & 2033 (%)
- 8.1.2. Clinical Decision Support
- 8.1.3. Genomic Data Interpretation
- 8.1.4. Data Analytics
- 8.1.5. Reporting & Visualization
- 8.1.6. Patient Case Management
- 8.1.7. Others
9. Molecular Tumor Board Solutions Market - By Cancer Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
- 9.1.2. Lung Cancer
- 9.1.3. Breast Cancer
- 9.1.4. Colorectal Cancer
- 9.1.5. Hematological Malignancies
- 9.1.6. Prostate Cancer
- 9.1.7. Melanoma
- 9.1.8. Others
10. Molecular Tumor Board Solutions Market - By End-Use
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
- 10.1.2. Hospitals
- 10.1.3. Specialized Cancer Centers
- 10.1.4. Research Institutes
- 10.1.5. Diagnostic Laboratories
- 10.1.6. Others
11. Molecular Tumor Board Solutions Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Molecular Tumor Board Solutions Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Molecular Tumor Board Solutions Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Molecular Tumor Board Solutions Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Molecular Tumor Board Solutions Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Molecular Tumor Board Solutions Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Molecular Tumor Board Solutions Industry
- 12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Roche
- 12.2.2. Tempus AI, Inc.
- 12.2.3. Caris Life Sciences
- 12.2.4. Illumina, Inc.
- 12.2.5. Thermo Fisher Scientific Inc.
- 12.2.6. Syapse, Inc.
- 12.2.7. GenomOncology, LLC
- 12.2.8. Molecular Health GmbH
- 12.2.9. SOPHiA GENETICS
- 12.2.10. QIAGEN N.V.
- 12.2.11. Guardant Health, Inc.
- 12.2.12. Myriad Genetics, Inc.
- 12.2.13. NantHealth, Inc.
- 12.2.14. MedGenome
- 12.2.15. CureMatch
- 12.2.16. Variantyx, Inc.
- 12.2.17. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
